Genetic Determinants of Amitriptyline Efficiency for Pain Treatment - Part II

NCT02256956 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Chronic Pain

Interventions

DRUG: Amitriptyline
DRUG: Tolterodine

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]
[object Object]
[object Object]